W.R. Berkley Corp’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.45M Buy
322,658
+49,708
+18% +$531K 0.16% 121
2026
Q1
$2.89M Buy
272,950
+99,420
+57% +$1.05M 0.16% 135
2025
Q4
$1.82M Hold
173,530
– – 0.09% 159
2025
Q3
$1.79M Hold
173,530
– – 0.1% 147
2025
Q2
$1.78M Hold
173,530
– – 0.09% 150
2025
Q1
$1.75M Buy
+173,530
New +$1.74M 0.1% 111

Other funds holding TDAC

W.R. Berkley Corp's TDAC Position: Q2 2026 in Review

W.R. Berkley Corp increased its Translational Development Acquisition Corp (TDAC) stake by 18% in Q2 2026, buying an estimated $531K and bringing the position to 322,658 shares worth $3.45M. The position accounts for 0.16% of the portfolio, ranked #121.

W.R. Berkley Corp first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • W.R. Berkley Corp held 322,658 shares of Translational Development Acquisition Corp worth $3.45M as of Q2 2026.
  • W.R. Berkley Corp bought 49,708 Translational Development Acquisition Corp shares in Q2 2026, an estimated $531K.
  • Translational Development Acquisition Corp made up 0.16% of W.R. Berkley Corp's portfolio in Q2 2026, its #121 holding.
  • W.R. Berkley Corp first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on W.R. Berkley Corp's 13F filing for Q2 2026, filed 14 Aug 2026.